Substance

ID:1055

Names and Identifiers
Brand Name
CinnasilNormorescinaRaurescinRescaloidRescaminRescinRescidanResealoidTsuruselpi STuaregRescinpalApoterin SCinatabsRaupyrolAnaprelApolonCinnaloidParesinanRaurescineRecitensinaReskinnaminTenamineAnapralApoterinCartricCinamineModerilRescisanRescitensResipalRozexScinnamina
Synonyms
Methyl TrimethoxycinnamoylreserpateReserpinineRecinnamineReserpineneReserpininRescinnamineTrimethoxycinnamoyl Methyl ReserpateRescinnamin
IUPAC Traditional name
rescinnamine
IUPAC name
methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate
Registration numbers
PubChem CID
CAS Number
PubChem SID
Properties
Physical Property
Hydrophobicity(logP)
3.5
Molecule Details
Drug Groups
approved
Description
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from Rauwolfia serpentina and other species of Rauwolfia. [Wikipedia]
Indication
For the treatment of hypertension.
Pharmacology
Used to treat hypertension. Rescinnamine inhibits angiotensin-converting enzyme. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex and general vasoconstriction, both of which lead to increases vascular resistance. By inhibiting angiotensin II, aldosterone reabsorption is decreased as well as vasoconstriction. This combined effect serves to decrease blood pressure.
Affected Organisms
Humans and other mammals
External Links
Molecular Spectra
Loading...
References
No Data Available
Click here to submit data